Dexlansoprazole MR in Nonerosive Reflux Disease

Not Applicable

• Conditions: Nonerosive Reflux Disease
• Interventions: Drug: Dexlansoprazole MR

• Registration Number: NCT02490449
• Lead Sponsor: Soonchunhyang University Hospital

Brief Summary

This study aim is to compare the efficacy of Dexlansoprazole MR intake before and after breakfast in patients with nonerosive reflux disease.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-12
• Study First Submitted: 2014-12-13
• Status Verified: 2015-07
• Study First Submitted QC: 2015-07-02
• Last Update Submitted: 2015-07-02
• Study First Posted: 2015-07-03
• Last Update Posted: 2015-07-03
• Primary Completion: 2015-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 356

Inclusion Criteria

• NERD confirmed by gastroscopy

Exclusion Criteria

• PPI medication within 2 weeks before enrollment

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Exprerimental group	Dexlansoprazole MR	medication after diet
control group	Dexlansoprazole MR	medication before diet

Primary Outcome Measures

Name	Time	Method
Percentage (%) of patients free of reflux symptoms	4 weeks

Trial Locations

Locations (1)

Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University College of Medicine; 🇰🇷 Bucheon, Gyeonggi-do, Korea, Republic of